Skip to main content
. Author manuscript; available in PMC: 2009 Oct 11.
Published in final edited form as: Int J Environ Res Public Health. 2008 Mar;5(1):41–48. doi: 10.3390/ijerph5010041

Figure 3.

Figure 3

Effect of dosing vehicle on time-course distribution of fluoranthene (FLA) metabolite concentrations in plasma, jejunum, feces, liver, lung, adipose, urine and feces of F-344 rats that received 25 μg FLA/kg body wt. via oral gavage. Values represent mean ± SE (n = 6). Asterisks denote statistical significance (p < 0.05) at the respective time point compared to 2 hour post-exposure.